Eton Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Eton Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Eton Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $21.5M, a 0.54% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $21.5M -$116K -0.54% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $21.6M +$3.08M +16.6% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $18.5M +$645K +3.6% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $17.9M +$8.17M +84% Dec 31, 2020 10-K 2022-03-16
Q4 2019 $9.73M +$5.38M +123% Dec 31, 2019 10-K 2021-03-16
Q4 2018 $4.36M +$2.58M +145% Dec 31, 2018 10-K 2020-03-05
Q4 2017 $1.78M Dec 31, 2017 10-K 2019-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.